123 related articles for article (PubMed ID: 8536102)
1. Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infection.
Kalinkovich A; Geleziunas R; Kemper O; Belenki D; Wallach D; Wainberg MA; Bentwich Z
J Interferon Cytokine Res; 1995 Sep; 15(9):749-57. PubMed ID: 8536102
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.
Cope AP; Aderka D; Wallach D; Kahan M; Chu NR; Brennan FM; Feldmann M
Immunology; 1995 Jan; 84(1):21-30. PubMed ID: 7890302
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
Joyce DA; Steer JH
J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
[TBL] [Abstract][Full Text] [Related]
4. Induction of soluble tumor necrosis factor receptor (sTNF-R75) release by HIV adsorption on cultured human monocytes.
Rimaniol AC; Boussin F; Herbelin A; De Groote D; Dormont D; Bach JF; Descamps-Latscha B; Zavala F
Eur J Immunol; 1994 Sep; 24(9):2055-60. PubMed ID: 8088326
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load.
Hestdal K; Aukrust P; Müller F; Lien E; Bjerkeli V; Espevik T; Frøland SS
Blood; 1997 Oct; 90(7):2670-9. PubMed ID: 9326234
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
7. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
8. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
[TBL] [Abstract][Full Text] [Related]
9. Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.
Granowitz EV; Saget BM; Angel JB; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):430-7. PubMed ID: 8605587
[TBL] [Abstract][Full Text] [Related]
10. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
Joyce DA; Steer JH
Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells.
Cope AP; Gibbons DL; Aderka D; Foxwell BM; Wallach D; Maini RN; Feldmann M; Brennan FM
Cytokine; 1993 May; 5(3):205-12. PubMed ID: 8218932
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen peroxide enhances shedding of type I soluble tumor necrosis factor receptor from pulmonary epithelial cells.
Hino T; Nakamura H; Abe S; Saito H; Inage M; Terashita K; Kato S; Tomoike H
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):122-8. PubMed ID: 9870925
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
[TBL] [Abstract][Full Text] [Related]
14. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
Modzelewski B
Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.
Brennan FM; Gibbons DL; Mitchell T; Cope AP; Maini RN; Feldmann M
Eur J Immunol; 1992 Jul; 22(7):1907-12. PubMed ID: 1320571
[TBL] [Abstract][Full Text] [Related]
16. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
18. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication.
Angel JB; Saget BM; Walsh SP; Greten TF; Dinarello CA; Skolnik PR; Endres S
AIDS; 1995 Oct; 9(10):1137-44. PubMed ID: 8519449
[TBL] [Abstract][Full Text] [Related]
19. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infection.
Aukrust P; Hestdal K; Lien E; Bjerkeli V; Nordøy I; Espevik T; Müller F; Frøland SS
J Infect Dis; 1997 Oct; 176(4):913-23. PubMed ID: 9333149
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
